MAPK1 and metabolic dysfunction-associated steatotic liver disease: Among the enriched pathways that emerged from the GSEA, the ERK signalling cascade was significantly downregulated by CHP, both in the WD/TN NAFLD and in the CCl4-induced liver disease models (Fig. 8A left panels; S6A).